Combination Therapy With 177Lu-FAPI-2286 and Tyrosine Kinase Inhibitor: A Novel Approach for Treating Metastatic Medullary Thyroid Carcinoma
Year: 2025
Type: article
Study design: Case Report
Source: Clinical Nuclear Medicine
Institution: Mashhad University of Medical Sciences
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409520810
